References
- 1Pierce SL, Zantow EW, Phillips SD, Williams M. Methamphetamine-associated cardiomyopathy in pregnancy: A case series. Mayo Clin Proc. 2019; 94(3): 551–4. DOI: 10.1016/j.mayocp.2018.12.008
- 2Whittaker A.
Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy by World Health Organization . Geneva, Switzerland: WHO (World Health Organization) Press, 2014 ISBN: 9789241548731, 224.http://www.who.int/substance_abu : Critiques. Drug Alcohol Rev. 2015; 34(3): 340–1. DOI: 10.1111/dar.12212 - 3World Health Organization.
Opioid overdose . WHO Press, 2023.https://www.who.int/news-room/fact-sheets/detail/opioid-overdose . - 4Seng J, Taylor J.
Trauma informed care in the perinatal period . Dunedin Academic Press; 2015. - 5Rutman D, Hubberstey C, Poole N, Schmidt RA, Van Bibber M. Multi-service prevention programs for pregnant and parenting women with substance use and multiple vulnerabilities: Program structure and clients’ perspectives on wraparound programming. BMC Pregnancy Childbirth. 2020; 20(1):
441 . DOI: 10.1186/s12884-020-03109-1 - 6Scaria MK. Role of care pathways in interprofessional teamwork. Nurs Stand. 2016; 30(52): 42–7. DOI: 10.7748/ns.2016.e10402
- 7Morgan S, Pullon S, McKinlay E. Observation of interprofessional collaborative practice in primary care teams: An integrative literature review. Int J Nurs Stud. 2015; 52(7): 1217–30. DOI: 10.1016/j.ijnurstu.2015.03.008
- 8Ordean A, Wong S, Graves L. No. 349-substance use in pregnancy. J Obstet Gynaecol Can. 2017; 39(10): 922–937.
e2 . DOI: 10.1016/j.jogc.2017.04.028 - 9Morton J, Konrad SC. Introducing a caring/relational framework for building relationships with addicted mothers. J Obstet Gynecol Neonatal Nurs. 2009; 38(2): 206–13. DOI: 10.1111/j.1552-6909.2009.01006.x
- 10Wright TE, Schuetter R, Fombonne E, Stephenson J, Haning WF
III . Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women. Harm Reduct J. 2012; 9(1). DOI: 10.1186/1477-7517-9-5 - 11McLafferty LP, Becker M, Dresner N, Meltzer-Brody S, Gopalan P, Glance J, et al. Guidelines for the management of pregnant women with substance use disorders. Psychosomatics. 2016; 57(2): 115–30. DOI: 10.1016/j.psym.2015.12.001
- 12Heaman MI, Martens PJ, Brownell MD, Chartier MJ, Thiessen KR, Derksen SA, et al. Inequities in utilization of prenatal care: a population-based study in the Canadian province of Manitoba. BMC Pregnancy Childbirth. 2018; 18(1): 430. DOI: 10.1186/s12884-018-2061-1
- 13Joudrey PJ, Bart G, Brooner RK, Brown L, Dickson-Gomez J, Gordon A, et al. Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report. Subst Abus. 2021; 42(3): 245–54. DOI: 10.1080/08897077.2021.1975344
- 14Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol. 2019; 221(1): B5–28. DOI: 10.1016/j.ajog.2019.03.022
- 15Gulbransen K, Thiessen K, Pidutti J, Watson H, Winkler J. Scoping review of best practice guidelines for care in the labor and birth setting of pregnant women who use methamphetamines. J Obstet Gynecol Neonatal Nurs. 2022; 51(2): 141–52.
https://www.semanticscholar.org/paper/72464a8ff81f776099b534d2ad247f5dd6a38380 . DOI: 10.1016/j.jogn.2021.10.008 - 16Krans EE, Campopiano M, Cleveland LM, Goodman D, Kilday D, Kendig S, et al. National Partnership for Maternal Safety: Consensus Bundle on Obstetric Care for women with Opioid Use Disorder: Consensus bundle on obstetric care for women with opioid use disorder. Obstet Gynecol. 2019; 134(2): 365–75. DOI: 10.1097/AOG.0000000000003381
- 17Raffi ER, Gray J, Conteh N, Kane M, Cohen LS, Schiff DM. Low barrier perinatal psychiatric care for patients with substance use disorder: meeting patients across the perinatal continuum where they are. Int Rev Psychiatry. 2021; 33(6): 543–52.
https://pubmed.ncbi.nlm.nih.gov/34406106/ . DOI: 10.1080/09540261.2021.1898351 - 18Perez FA, Blythe S, Wouldes T, McNamara K, Black KI, Oei JL. Prenatal methamphetamine-impact on the mother and child-a review. Addiction. 2022; 117(1): 250–60. DOI: 10.1111/add.15509
- 19New South Walesw ministry of health. Clinical guidelines for the management of substance use during pregnancy, birth, and the postnatal period. NSW Ministry of Health. 2014; 1–148.
https://www.health.nsw.gov.au/aod/professionals/Publications/substance-use-during-pregnancy-guidelines.pdf . - 20Jansson LM, Svikis D, Lee J, Paluzzi P, Rutigliano P, Hackerman F. Pregnancy, and addiction. A comprehensive care model. J Subst Abuse Treat. 1996; 13(4): 321–9.
https://pubmed.ncbi.nlm.nih.gov/9076650/ . DOI: 10.1016/S0740-5472(96)00070-0 - 21Government of Canada. Canadian tobacco, alcohol, and drugs survey (CTADS): summary of results for 2017. Gov of Canada. 2023.
https://www.canada.ca/en/health-canada/services/canadian-alcohol-drugs-survey/2017-summary.html . - 22Kalaitzopoulos D-R, Chatzistergiou K, Amylidi A-L, Kokkinidis DG, Goulis DG. Effect of methamphetamine hydrochloride on pregnancy outcome: A systematic review and meta-analysis: A systematic review and meta-analysis. J Addict Med. 2018; 12(3): 220–6.
https://pubmed.ncbi.nlm.nih.gov/29509557/ . DOI: 10.1097/ADM.0000000000000391 - 23Holt K, French G. Exploring the motherhood experiences of active methamphetamine users. Crime Law Soc Change. 2020; 73(3): 297–314. DOI: 10.1007/s10611-019-09862-5
- 24Mahoney K, Reich W, Urbanek S. Substance use disorder: Prenatal, intrapartum, and postpartum care. MCN Am J Matern Child Nurs. 2019; 44(5): 284–8.
https://pubmed.ncbi.nlm.nih.gov/31415268/ . DOI: 10.1097/NMC.0000000000000551 - 25Weber A, Miskle B, Lynch A, Arndt S, Acion L. Substance use in pregnancy: Identifying stigma and improving care. Subst Abuse Rehabil. 2021; 12: 105–21.
https://www.semanticscholar.org/paper/8c738d65043427249226b009ad52cc1a6dc902ea . DOI: 10.2147/SAR.S319180 - 26Nathoo T, Poole N, Bryans M, Dechief L, Hardeman S, Marcellus L, et al. Voices from the community: Developing effective community programs to support pregnant and early parenting women who use alcohol and other substances. First Peoples Child Fam Rev. 2013; 8(1): 93.
https://www.semanticscholar.org/paper/a5f39793525b6e4971e8dfaf98affd1a7b47a70e . - 27Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005; 8(1): 19–32.
https://www.semanticscholar.org/paper/f12499d98165f62f07f928f913bc184a1be6045c . DOI: 10.1080/1364557032000119616 - 28Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010; 5(1):
69 .https://pubmed.ncbi.nlm.nih.gov/20854677/ . DOI: 10.1186/1748-5908-5-69 - 29Gulbransen K, Thiessen K. Interprofessional care models for pregnant and early-parenting persons who use substances. Open Science Framework; 2023. DOI: 10.17605/OSF.IO/HNVA7
- 30Tricco AC, Lillie E, Zarin W, O’Brien K, Colquhoun H, Kastner M, et al. A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol. 2016; 16(1): 15.
https://pubmed.ncbi.nlm.nih.gov/26857112/ . DOI: 10.1186/s12874-016-0116-4 - 31Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016; 104(3): 240–3.
https://pubmed.ncbi.nlm.nih.gov/27366130/ . DOI: 10.3163/1536-5050.104.3.014 - 32PRISMA.
Prisma-statement.org .https://prisma-statement.org/Extensions/ScopingReviews?AspxAutoDetectCookieSupport=1 . - 33Hodgins FE, Lang, JM, Malseptic GG, Melby LH, Connoly KA. Coordinating outpatient care for pregnant and postpartum women with opioid use disorder: Implications for the COACHH program. Matern Child Health J. 2019 May; 23(5): 585–591. PMID: 30604105. DOI: 10.1007/s10995-018-2683-y
- 34Rutman D, Hubberstey C. National evaluation of Canadian multi-service FASD prevention programs: Interim findings from the Co-Creating Evidence study. Int J Environ Res Public Health. 2019; 6(10):
1767 .https://pubmed.ncbi.nlm.nih.gov/31109087/ . DOI: 10.3390/ijerph16101767 - 35Jones C, Duea S, Griggs K, Johnstone W Jr, Kinsey D. Improving outcomes of mothers with Opioid Use Disorder using a community collaborative model. J Prim Care Community Health. 2021; 12:
21501327211052400 . DOI: 10.1177/21501327211052401 - 36Mckinney JR, Russell M, Avellaneda-Ojeda A, Gannon C, Zambare S, Hansford M, et al. A comprehensive care approach for pregnant persons with substance use disorders. Int J Ment Health Addict. 2022; DOI: 10.1007/s11469-022-00760-x
- 37Mitchell E, Hall J, Campbell D, van Teijlingen E. Specialist care for drug using pregnant women. Br J Midwifery. 2003; 11(1): 7–11. DOI: 10.12968/bjom.2003.11.1.11017
- 38O’Connor A, McLaurin R. Comprehensive care for women with alcohol and other drug use: The women and newborn drug and alcohol service, Perth. Australian Midwifery News. 2016; 16(3): 20–1.
https://search.informit.org/doi/abs/10.3316/informit.366788483443264 - 39Ordean A, Kahan M. Comprehensive treatment program for pregnant substance users in a family medicine clinic. Can Fam Physician. 2011; 57(11): e430–5.
http://www.cfp.ca/content/57/11/e430.abstract . - 40Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, et al. Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstet Gynecol. 2018; 132(2): 466–74.
https://pubmed.ncbi.nlm.nih.gov/29995730/ . DOI: 10.1097/AOG.0000000000002734 - 41Suffet F, Brotman R. A comprehensive care program for pregnant addicts: obstetrical, neonatal, and child development outcomes. Int J Addict. 1984; 19(2): 199–219.
https://www.semanticscholar.org/paper/c279d17e8c9111fc43bd8c367e972169c5fff556 . DOI: 10.3109/10826088409057176 - 42Henry R, Lavallee A, Van Styvendale N, Innes R. Global Indigenous Health: Reconciling the Past, Engaging the Present, Animating the Future. 2018;
https://www.semanticscholar.org/paper/45f642bd0a18282d37b559f86cc3fd22d056738a . - 43Rowan M, Poole N, Shea B, Gone JP, Mykota D, Farag M, et al. Cultural interventions to treat addictions in Indigenous populations: findings from a scoping study. Subst Abuse Treat Prev Policy. 2014; 9(1): 34.
https://pubmed.ncbi.nlm.nih.gov/25179797/ . DOI: 10.1186/1747-597X-9-34 - 44Hatzenbuehler ML, Jun H-J, Corliss HL, Bryn Austin S. Structural stigma, and sexual orientation disparities in adolescent drug use. Addict Behav. 2015; 46: 14–8.
https://pubmed.ncbi.nlm.nih.gov/25753931/ . DOI: 10.1016/j.addbeh.2015.02.017 - 45Chambers BD, Erausquin JT. Race, sex, and discrimination in school settings: A multilevel analysis of associations with delinquency: Race, sex, and discrimination in school settings: A multilevel analysis of associations with delinquency. J Sch Health. 2018; 88(2): 159–66.
https://www.semanticscholar.org/paper/6f78301d5d2d3ae0b0189d07de3d9a741e7d5033 . DOI: 10.1111/josh.12589 - 46Government of Canada. Strengthening Canada’s Approach to Substance Use Issues. 2018.
https://www.canada.ca/en/health-canada/services/substance-use/canadian-drugs-substances-strategy/strengthening-canada-approach-substance-use-issue.html . - 47Marcellus L, MacKinnon K, Benoit C, Phillips R, Stengel C. Reenvisioning success for programs supporting pregnant women with problematic substance use. Qual Health Res. 2015; 25(4): 500–12.
https://www.semanticscholar.org/paper/6a193dbed515a85b55b333818e42e18e395fb417 . DOI: 10.1177/1049732314551058